Skip to main content

Mother-Daughter Kayaking Team to Complete 300-Mile Trip in Baltimore to Honor Late UM SOM Scientist Dr. Angela Brodie

August 15, 2017 | Joanne Morrison

Carolyn Choate and her daughter Sydney Turnbull

Breast Cancer Survivor Embarks on Trip to Raise Awareness and Support for Future Research at UM SOM

Patients who receive life-saving care from a physician or surgeon are often so grateful that they make generous gifts to medical schools and hospitals where they were treated.

One grateful patient --breast cancer survivor Carolyn Choate, 59, -- has taken her gratitude a step further, or in this case, 300 miles further. Not just thankful for the breast cancer treatment she received, she is forever indebted to the scientist, the late Angela Brodie, PhD, who originally discovered the treatment, and she wants others to know about it.

As a result, Carolyn and her daughter Sydney Turnbull, 27, have just launched a 300-mile “River of Life” kayaking journey that will take them from Port Jervis, NY, on the Delaware River, all the way to Baltimore’s Inner Harbor, where they will arrive on August 27. Their goal: Raise awareness and support along the way for future generations of breast cancer research at the University of Maryland School of Medicine (UM SOM), where Dr. Brodie conducted her groundbreaking research for nearly 40 years, until her passing in June of this year.

The mother-daughter team, which is expected to complete their 17-day kayaking journey in Baltimore on August 27 at 9:00 a.m. near the amphitheater between the Pratt and Light Street Pavilions, have been raising support for a Distinguished Professorship in honor of Dr. Brodie, Ph.D., who is recognized internationally for pioneering the use of aromatase inhibitors to treat a common form of breast cancer.

Ms. Choate credits Dr. Brodie’s work with saving her life. “It’s important to me that I do whatever I can to honor Dr. Brodie and continue to support the kind of innovation that, quite literally, saved my life, and the lives of countless other women,” said Ms. Choate, who has raised money and awareness for breast cancer research by advocating at home and abroad.

With the goal of raising $500,000 to complete a $2.5 million Distinguished Professorship in honor of Dr. Brodie, the mother-daughter team said they are celebrating the millions of women diagnosed and recovering from breast cancer, the exceptional research and development like Dr. Brodie’s that has saved many lives so far, and the promise of future generations of research in this critical area.

On August 28, Ms. Choate will be recognized by the Baltimore Orioles during their game against the Seattle Mariners. Learn more about this event.

“Dr. Angela Brodie’s impact on the treatment of breast cancer has been unparalleled, saving thousands of lives around the world. We are appreciative of this tremendous effort to honor her work and support future generations of life-saving research at the University of Maryland School of Medicine,” said E. Albert Reece, MD, PhD, MBA, Vice President for Medical Affairs at the University of Maryland and the John Z. and Akiko K. Bowers Distinguished Professor and Dean of the University of Maryland School of Medicine.

About Angela Hartley Brodie, PhD

Dr. Brodie, a fourth-generation scientist, passed away on June 7. She was professor emeritus of pharmacology and experimental therapeutics at UM SOM and an internationally recognized researcher at the University of Maryland Marlene and Stewart Greenebaum Comprehensive Cancer Center. She pioneered the development of aromatase inhibitors, which help to prevent the recurrence of breast cancer in postmenopausal women with estrogen-sensitive cancer by reducing the level of the estrogen in the body. Dr. Brodie’s distinguished career at the University of Maryland spanned 37 years until her retirement in 2016.

About the University of Maryland School of Medicine

Commemorating its 210th Anniversary, the University of Maryland School of Medicine was chartered in 1807 as the first public medical school in the United States. It continues today as one of the fastest growing, top-tier biomedical research enterprises in the world -- with 43 academic departments, centers, institutes, and programs; and a faculty of more than 3,000 physicians, scientists, and allied health professionals, including members of the National Academy of Sciences, and a distinguished recipient of the Albert E. Lasker Award in Medical Research. With an operating budget of more than $1 billion, the School of Medicine works closely in partnership with the University of Maryland Medical Center and Medical System to provide research-intensive, academic and clinically-based care for more than 1.2 million patients each year. The School has over 2,500 students, residents, and fellows, and nearly $450 million in extramural funding, with more than half of its academic departments ranked in the top 20 among all public medical schools in the nation in research funding. As one of the seven professional schools that make up the University of Maryland, Baltimore campus, the School of Medicine has a total workforce of nearly 7,000 individuals. The combined School and Medical System (“University of Maryland Medicine”) has a total budget of $5 billion and an economic impact of nearly $15 billion on the state and local community. The School of Medicine faculty, which ranks as the 8th-highest public medical school in research productivity, is an innovator in translational medicine with 600 active patents and 24 start-up companies. The School works locally, nationally, and globally, with research and treatment facilities in 36 countries around the world. Visit


Learn More

• UM Marlene and Stewart Greenebaum Comprehensive Cancer Center

• River of Life Tribute Challenge: Honoring Dr. Angela Brodie Website

•  Donate to Support Breast Cancer Research at UMSOM


Department of Anesthesiology
(410) 328-6120 (phone)
(410) 328-5531 (fax)

University of Maryland School of Medicine
Joanne Morrison
Director of Marketing and Public Relations
University of Maryland School of Medicine
Office:(410) 706-2884
Mobile:(202) 841-3369

Related stories

    Tuesday, April 04, 2023

    UM School of Medicine Study Finds ChatGPT Helpful for Breast Cancer Screening Advice, With Certain Caveats

    As more consumers turn to the newly available ChatGPT for health advice, researchers are eager to see whether the information provided by the artificial intelligence chatbot is reliable and accurate. A new study conducted by researchers at the University of Maryland School of Medicine (UMSOM) indicates that the answers generated provide correct information the vast majority of the time; sometimes, though, the information is inaccurate or even fictitious.

    Monday, October 29, 2018

    UMSOM Honors Breast Cancer Awareness Month, Our Research Continues Toward Combating this Disease

    October is Breast Cancer Awareness Month, and researchers at the University of Maryland School of Medicine (UMSOM) continue in their work to help combat this disease that impacts more than 315,000 women in the U.S. each year.

    Thursday, June 07, 2018

    Most Early-Stage Breast Cancer Patients with Intermediate Risk of Recurrence can Safely Avoid Chemotherapy

    The majority of women with early-stage estrogen receptor (ER)-positive breast cancer, considered at intermediate risk of having their cancer recur based on a 21-gene test, can safely forgo treatment with chemotherapy, according to a large multicenter clinical study published in the New England Journal of Medicine.

    Monday, August 07, 2017

    New Study Reveals How Breast Cancer Can Grow if Untreated

    In 2017, more than 315,000 women in the U.S. are expected to be diagnosed with breast cancer. More than 40,000 are expected to die in 2017 from the disease. Over the course of their lives, one in 8 women in this country will develop invasive breast cancer.

    Wednesday, June 07, 2017

    In Memoriam: Angela Hartley Brodie, Ph.D., Internationally Renowned Breast Cancer Researcher at University of Maryland School of Medicine

    Angela Hartley Brodie, PhD, Professor Emeritus in the Department of Pharmacology at the University of Maryland School of Medicine, and an internationally recognized scientist whose groundbreaking cancer research is considered among the greatest advances in treating breast cancer, passed away of complications from Parkinson’s disease at her home in Fulton, MD. She was 82.

    Thursday, November 10, 2016

    Top Cancer Scientists Speak at the Fourth Annual Festival of Science

    More than 500 people saw leading cancer scientists discuss their cutting-edge work at the fourth annual University of Maryland School of Medicine (UM SOM) Festival of Science, a one-day celebration of research at the school held November 10, 2016 the SMC Campus Center. The conference, titled “Cancer Research: Translational Discoveries to Next Generation Treatments,” featured a range of UM SOM’s top cancer researchers, who are working on the front lines of science to unravel crucial problems involving cancer in its many forms.